97 related articles for article (PubMed ID: 7706859)
1. [Autologous blood transfusion with recombinant human erythropoietin and hypotensive anesthesia in operation for gynecological malignant tumors].
Ikebuchi Y; Shimizu H; Moriyama A; Kubota Y; Nohara A; Nishimura Y
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):169-72. PubMed ID: 7706859
[No Abstract] [Full Text] [Related]
2. [The application of autologous blood transfusion and hypotensive anesthesia for radical hysterectomy in uterine cancer].
Yamasaki M; Ohama K; Hisamatsu K; Okamoto E; Tanaka F; Takemura M; Okada T
Gan No Rinsho; 1988 Sep; 34(11):1572-8. PubMed ID: 3184463
[TBL] [Abstract][Full Text] [Related]
3. The simultaneous use of autologous blood transfusion and hypotensive anesthesia to the radical hysterectomy for uterine carcinomas.
Yamasaki M; Sawada M; Urabe T; Okamoto E; Shimizu H; Takemura M; Ohama K
Asia Oceania J Obstet Gynaecol; 1989 Dec; 15(4):317-24. PubMed ID: 2624574
[TBL] [Abstract][Full Text] [Related]
4. [Effect of preoperative treatment with recombinant human erythropoietin in patients undergoing hemodilutional autologous transfusion].
Nakae Y; Sonoda H; Miyabe M; Kawamata M; Sakakibara N; Kawana S; Namiki A
Masui; 1995 Oct; 44(10):1362-8. PubMed ID: 8538004
[TBL] [Abstract][Full Text] [Related]
5. Autologous blood transfusion using recombinant human erythropoietin in radical hysterectomy.
Yamawaki T; Tanaka H; Takeuchi S; Yanase H; Taniguchi H; Toyoda N
Asia Oceania J Obstet Gynaecol; 1994 Jun; 20(2):147-53. PubMed ID: 8092959
[TBL] [Abstract][Full Text] [Related]
6. Observation of coagulation change during induced hypotensive anesthesia and autologous plasma transfusion.
Liu YC; Ho WM; Kang HM; Tso HS
Acta Anaesthesiol Sin; 1994 Sep; 32(3):159-64. PubMed ID: 7921860
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of autologous blood transfusion in patients undergoing radical hysterectomy.
Pellegrino A; Landoni F; Cormio G; Ferrando P; Lissoni A; Scalambrino S; Mangioni C
Ann Chir Gynaecol; 1995; 84(4):391-4. PubMed ID: 8687086
[TBL] [Abstract][Full Text] [Related]
8. Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: use of recombinant human erythropoietin.
Kajikawa M; Nonami T; Kurokawa T; Hashimoto S; Harada A; Nakao A; Takagi H
Surgery; 1994 Jun; 115(6):727-34. PubMed ID: 8197566
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery.
Schmoeckel M; Nollert G; Mempel M; Mempel W; Reichart B
Thorac Cardiovasc Surg; 1993 Dec; 41(6):364-8. PubMed ID: 8128466
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin--does it increase the efficiency of autologous blood donation?
Goodnough LT
Beitr Infusionsther; 1993; 29():240-50. PubMed ID: 7690657
[No Abstract] [Full Text] [Related]
11. [Isovolemic hemodilution for avoiding homologous blood transfusions: effectiveness in large gynecologic interventions].
Oberhauser M; Bardenheuer HJ; Bernasconi H; Genz T; Kreimeier U
Infusionsther Transfusionsmed; 1996 Feb; 23(1):15-23. PubMed ID: 8653011
[TBL] [Abstract][Full Text] [Related]
12. Predeposit autologous blood transfusion in elderly patients undergoing transurethral resection of the prostate.
Ihara H; Yabumoto H; Shima H; Mori Y; Ikoma F
Int Urol Nephrol; 1993; 25(6):571-6. PubMed ID: 7513679
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of recombinant human erythropoietin on predeposit autologous blood transfusion in patients undergoing radical prostatectomy].
Hashine K; Karashima T; Kasahara K; Sumiyoshi Y
Hinyokika Kiyo; 1997 Jun; 43(6):411-4. PubMed ID: 9250490
[TBL] [Abstract][Full Text] [Related]
14. [Changes in hematological indices, iron levels and marrow erythroids through autologous blood donation before cardiac surgery--predonation with versus without recombinant human erythropoietin].
Shinonaga M
Nihon Kyobu Geka Gakkai Zasshi; 1995 Apr; 43(4):479-87. PubMed ID: 7608597
[TBL] [Abstract][Full Text] [Related]
15. Optimizing autologous blood donation by recombinant human erythropoietin (rhu-EPO) and interleukin 3 (IL-3).
Krieter H; Frey L; Segiet W; Brückner UB; Krumwieh D; Seiler FR; Messmer K
Behring Inst Mitt; 1991 Dec; (90):75-85. PubMed ID: 1801694
[TBL] [Abstract][Full Text] [Related]
16. [A double-blind dose ranging study of weekly subcutaneous administration of rHuEPO (KRN5702) on post-phlebotomy anemia of patients scheduled for predeposit autologous blood transfusion (multicenter late PhII study)].
Tsutsui H; Sugioka Y; Takaku F; Yamamura H; Asano S; Minami S; Wakimoto N; Takahashi K; Ikeda Y; Tachibana S
Nihon Seikeigeka Gakkai Zasshi; 1993 Oct; 67(10):919-34. PubMed ID: 8263364
[TBL] [Abstract][Full Text] [Related]
17. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
18. [Effect of recombinant human erythropoietin on autologous blood donation for heart surgery].
Szöcs M; Donauer E; Simon J; Gál G; Kovács G
Orv Hetil; 1995 Aug; 136(33):1777-81. PubMed ID: 7651714
[TBL] [Abstract][Full Text] [Related]
19. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation.
Goodnough LT; Verbrugge D; Marcus RE; Goldberg V
J Am Coll Surg; 1994 Aug; 179(2):171-6. PubMed ID: 8044386
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant human erythropoietin (epoetin) and autologous blood transfusion in chronic hemodialysis. Apropos of 2 cases].
Montagnac R; Ebikili B; Schillinger F
Nephrologie; 1997; 18(1):23-6. PubMed ID: 9121601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
